Angela Villalba-Moreno
Overview
Explore the profile of Angela Villalba-Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Ramallo H, Baez-Gutierrez N, Villalba-Moreno A, Jaramillo Ruiz D, Santos-Ramos B, Prado-Mel E, et al.
Arch Gerontol Geriatr
. 2024 Feb;
121:105365.
PMID: 38364710
Objectives: To describe the extent, characteristics, and knowledge gaps regarding explicit decision criteria for deprescribing drugs with anticholinergic or sedative properties (Ach/Sed) in older adults. Design: Scoping review. Setting And...
2.
Tristancho-Perez A, Villalba-Moreno A, Lopez-Malo de Molina M, Santos-Ramos B, Sanchez-Fidalgo S
J Clin Med
. 2022 Jun;
11(12).
PMID: 35743428
Anticholinergic burden (AB) is related to cognitive impairment (CI) and older complex chronic patients (OCCP) are more susceptible. Our objective was to evaluate the predictive value of ten anticholinergic scales...
3.
Tristancho-Perez A, Villalba-Moreno A, Santos-Rubio M, Belda-Rustarazo S, Santos-Ramos B, Sanchez-Fidalgo S
J Patient Saf
. 2021 Oct;
18(4):e816-e821.
PMID: 34693926
Objective: The aim of the study was to evaluate the concordance among 10 anticholinergic scales for the measurement of anticholinergic drug exposure in at-risk elderly complex chronic patients in primary...
4.
Tristancho-Perez A, Villalba-Moreno A, Santos-Rubio M, Lopez-Malo M, Santos-Ramos B, Sanchez-Fidalgo S
Curr Pharm Des
. 2021 Aug;
27(40):4186-4194.
PMID: 34463225
Background: Elderly patients with multiple chronic conditions are closely linked to polymedication, a condition that is also highly associated with the presence of adverse effects, such as those observed by...
5.
Villalba-Moreno A, Alfaro-Lara E, Sanchez-Fidalgo S, Santos-Ramos B
Farm Hosp
. 2020 Jan;
43(5):170-171.
PMID: 31961785
No abstract available.
6.
Rodriguez-Perez A, Alfaro-Lara E, Sierra-Torres M, Villalba-Moreno A, Nieto-Martin M, Galvan-Banqueri M, et al.
Eur J Hosp Pharm
. 2019 Dec;
26(6):334-338.
PMID: 31798857
Objective: The 'LESS-CHRON criteria' (List of Evidence-Based Deprescribing for Chronic Patients criteria) is a newly created tool with 27 criteria to guide deprescribing. It was developed using a Delphi methodology....
7.
Villalba-Moreno A, Alfaro-Lara E, Sanchez-Fidalgo S, Nieto-Martin M, Santos-Ramos B
Farm Hosp
. 2017 Aug;
41(5):647-648.
PMID: 28847259
No abstract available.
8.
Perez-Moreno M, Galvan-Banqueri M, Flores-Moreno S, Villalba-Moreno A, Cotrina-Luque J, Bautista-Paloma F
Int J Clin Pharm
. 2014 Mar;
36(3):476-87.
PMID: 24590919
Introduction: Lung cancer accounts for 20 % of cancer deaths in Spain. The most frequent subtype (87 %) is non-small cell lung cancer (NSCLC). Pemetrexed is a recently marketed drug...